Shareholders Foundation, Inc.

Investor Investigation over Potential Wrongdoing at Genesis Healthcare Inc (NYSE:GEN)

An investigation on behalf of investors in Genesis Healthcare Inc (NYSE:GEN) shares over potential wrongdoing at Genesis Healthcare was announced and NYSE:GEN stockholders should contact the Shareholders Foundation

 

San Diego, CA -- (SBWIRE) -- 05/27/2016 -- An investigation was announced for stockholders of of Genesis Healthcare Inc (NYSE:GEN) was announced over potential breaches of fiduciary duties by certain directors at Genesis Healthcare.

Investors who purchased shares of Genesis Healthcare Inc (NYSE:GEN) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Genesis Healthcare officers and directors breached their fiduciary duties.

Genesis Healthcare Inc reported that its annual Total Revenue rose from over $4.76 billion in 2014 to over $5.61 billion in 2015 while its Net Loss increased from $239.94 million in 2014 to $424.98 million in 2015.

Shares of Genesis Healthcare Inc (NYSE:GEN) declined from as high as $9.22 per share in January 2015 to as low as $1.42 per share in February 2016.

On May 25, 2016, NYSE:GEN shares closed at $1.86 per share.

Those who purchased shares of Genesis Healthcare Inc have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com